PD-1 targeted Immunotherapy as first-line therapy for advanced non-small-cell lung cancer patients

Gelijkaardige items

• First-line immunotherapy in advanced non-small-cell lung cancer
  door: Vanita Noronha, et al.
  Gepubliceerd in: (2019-01-01)
• Nivolumab as first line monotherapy for advanced non-small cell lung cancer: could we replace first line chemotherapy with immunotherapy?
  door: West, Howard
  Gepubliceerd in: (2014)
• First line Immunotherapy for Non-Small Cell Lung Cancer
  door: Nasser, Nicola J., et al.
  Gepubliceerd in: (2020)
• First-line immunotherapy for patients with advanced stage or metastatic non-small cell lung cancer…finally what threshold of PD-L1 expression on tumor cells?
  door: Hofman, Paul
  Gepubliceerd in: (2019)
• Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer
  door: Schulze, Arik Bernard, et al.
  Gepubliceerd in: (2019)